Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis

Journal of Infectious Diseases

Volumn 205, Issue 3, 2012, Pages 491-497

  Yun, Soo Hyeon ^a   Lee, Won Gil ^b   Kim, Yong Chul ^b   Ju, Eun Seon ^a   Lim, Byung Kwan ^c   Choi, Jin Oh ^a   Kim, Duk Kyung ^a   Jeon, Eun Seok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3C PROTEASE INHIBITOR; DIMETHYL SULFOXIDE; POLYPROTEIN; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DOWN REGULATION; DRUG MECHANISM; EXPERIMENTAL MOUSE; HEART MUSCLE FIBROSIS; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MALE; MORTALITY; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN DEGRADATION; SURVIVAL RATE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS MYOCARDITIS; VIRUS SURVIVAL;

ANIMALS; ANTIVIRAL AGENTS; COXSACKIEVIRUS INFECTIONS; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; ENZYME INHIBITORS; HEART; HISTOCYTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY; MYOCARDITIS; MYOCARDIUM; PANCREAS; SURVIVAL ANALYSIS; VIRAL LOAD; VIRAL PROTEINS;

EID: 84862955845     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir745     Document Type: Article

References (24)

1. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
2. D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001;85:499-504. (Pubitemid 32973488)
3. Rueckert RR. Picornaviridae: The viruses and the replication. Fundamental virology, Third ed. 1996:477-522.
4. Yu SF, Benton P, Bovee M, Sessions J, Lloyd RE. Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity. J Virol 1995;69:247-52. (Pubitemid 24378800)
5. Lall MS, Jain RP, Vederas JC. Inhibitors of 3C cysteine proteinases from Picornaviridae. Curr Top Med Chem 2004;4:1239-53. (Pubitemid 39172335)
6. Patick AK, Binford SL, Brothers MA, et al. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 1999;43:2444-50. (Pubitemid 29471225)
7. Lee ES, Lee WG, Yun SH, et al. Development of potent inhibitors of the coxsackievirus 3C protease. Biochem Biophys Res Commun 2007;358:7-11. (Pubitemid 46719074)
8. Arnold E, Rossmann MG. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A. J Mol Biol 1990;211:763-801. (Pubitemid 20113663)
9. Hadfield AT, Lee W, Zhao R, et al. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure 1997;5:427-41. (Pubitemid 27169943)
10. Sakamoto M, Takeuchi Y, Umeda M, Ishikawa I, Benno Y. Rapid detection and quantification of five periodontopathic bacteria by real-time PCR. Microbiol Immunol 2001;45:39-44. (Pubitemid 32142182)
11. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 1996;70:7811-8. (Pubitemid 26339087)
12. Lim BK, Choe SC, Shin JO, et al. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. Circulation 2002;105:1278-81.
13. Bovee ML, Marissen WE, Zamora M, Lloyd RE. The predominant eIF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease. Virology 1998;245:229-40. (Pubitemid 28394185)
14. Goldstaub D, Gradi A, Bercovitch Z, et al. Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol 2000;20:1271-7. (Pubitemid 30069248)
15. Sommergruber W, Ahorn H, Klump H, et al. 2A proteinases of coxsackie-and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. Virology 1994;198:741-5.
16. Badorff C, Lee GH, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999;5:320-6. (Pubitemid 29124369)
17. Baxter NJ, Roetzer A, Liebig HD, et al. Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease. J Virol 2006;80:1451-62. (Pubitemid 43134102)
18. Seipelt J, Liebig HD, Sommergruber W, Gerner C, Kuechler E. 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. J Biol Chem 2000;275:20084-9. (Pubitemid 30441618)
19. Clark ME, Lieberman PM, Berk AJ, Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol 1993;13:1232-7. (Pubitemid 23040290)
20. Yalamanchili P, Datta U, Dasgupta A. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J Virol 1997;71:1220-6. (Pubitemid 27030295)
21. Yalamanchili P, Weidman K, Dasgupta A. Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro. Virology 1997;239:176-85. (Pubitemid 28027081)
22. Chau DH, Yuan J, Zhang H, et al. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 2007;12:513-24.
23. Bahri O, Rezig D, Nejma-Oueslati BB, et al. Enteroviruses in Tunisia: virological surveillance over 12 years (1992-2003). J Med Microbiol 2005;54:63-9.
24. Lim BK, Choi JH, Nam JH, et al. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc Res 2006;71:517-26.